Atlas Trials

Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition

Clinical trial NCT00968097 · TERMINATED

Trial details

NCT number
NCT00968097
Sponsor
Institute for Neurodegenerative Disorders
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2008-04-01
Primary completion
2008-07-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.